Genomics Market Report 2026

The genomics market size has grown rapidly in recent years. It will grow from $50.23 billion in 2025 to $58.44 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to human genome project completion, sequencing technology advancements, growth of academic genomics research, government funding initiatives, declining sequencing costs.

The genomics market size is expected to see rapid growth in the next few years. It will grow to $107.56 billion in 2030 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to population genomics initiatives, integration with healthcare systems, expansion of agricultural genomics, increased biopharma investment, development of multi-omics platforms. Major trends in the forecast period include expansion of large-scale genomic research programs, increasing adoption of next-generation sequencing, growing demand for precision medicine solutions, rising use of genomics in drug discovery, increased investment in genomic infrastructure.

Increasing government funding for genomics research is expected to drive the growth of the single-cell genomics market. These funds are aimed at addressing the complexity of the human genome, understanding the genomic basis of health and disease, and ensuring the safe application of genomics to improve patient care and benefit society through government, public, and private institutions. For example, in March 2024, the National Human Genome Research Institute (NHGRI), a US-based government research institute, reported that the FY 2025 President’s Budget request for NHGRI is $663.7 million, representing an increase of $3.2 million compared with the FY 2023 final level. As a result, the rise in government funding for genomics research is expected to propel the genomics market.

Key players in the genomics market are focusing on technological innovations such as long-read sequencing technology to improve genome sequencing accuracy, enable analysis of larger and more complex genetic regions, and provide deeper insights into genetic variations that were previously difficult to detect. Long-read technology involves sequencing longer DNA or RNA segments, allowing for more precise and comprehensive genetic analysis and better identification of complex variations and disease-associated markers. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, introduced Illumina’s Complete Long Read Prep, which offers an efficient, low-input solution for whole-genome sequencing. This technology delivers both long- and short-read data on a single device, with simplified workflows and reduced material requirements compared to other sequencing methods.

In July 2024, Petrosys Pty Ltd, an Australia-based software company, acquired Talus Technologies Inc. for an undisclosed sum. Through this acquisition, Petrosys Pty Ltd aims to enhance its software offerings for the energy and resource sectors, with a particular focus on improving data visualization capabilities. Talus Technologies Inc. is a Canada-based company specializing in the discovery and development of therapeutics targeting transcription factors (TFs).

Major companies operating in the genomics market are 10X Genomics Inc., Qiagen NV, Standard BioTools Inc., Illumina Inc., Affymetrix Inc., Angle plc, Denovo Sciences Inc., Diagnologix LLC, DNA Electronics Ltd., Epic Sciences, Kellbenx Inc., Resolution Bioscience Inc., Wafergen Bio-systems Inc., Yikon Genomics Co. Ltd., Thermo Fisher Scientific Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Cell Microsystems Inc., CellSorter, CYTENA GmbH, Dolomite Bio Limited, Agilent Technologies Inc., Fluxion Biosciences Inc., BGI Group, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Eurofins Scientific SE, PerkinElmer Inc.

North America was the largest region in the genomics market in 2025. Western Europe was the second largest region in the genomics market. The regions covered in the genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the genomics market by increasing costs of imported sequencing instruments, reagents, and analytical software. Academic institutes and biopharmaceutical companies are most affected due to reliance on imported technologies. These tariffs increase research costs by raising capital expenditure and ongoing consumable expenses, slowing large-scale genomic studies and platform upgrades. However, they encourage domestic genomics manufacturing, supporting local development of sequencing hardware, reagents, and bioinformatics solutions.

The genomics market research report is one of a series of new reports that provides genomics market statistics, including genomics industry global market size, regional shares, competitors with a genomics market share, detailed genomics market segments, market trends and opportunities, and any further data you may need to thrive in the genomics industry. This genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Genomics is the study of an organism’s complete set of genes (genome), encompassing their structure, function, evolution, and mapping. It involves analyzing the sequencing and interactions of DNA, RNA, and proteins to understand how genes regulate biological processes and influence traits and diseases. Genomics is essential in areas such as medicine, agriculture, and biotechnology, contributing to advances in personalized medicine, enhanced crop production, and the development of targeted therapies for genetic disorders.

The main product categories in genomics include instruments (covering systems, service contracts, and software) and reagents (including reagents and consumables). A reagent is a substance or compound introduced into a system to trigger a chemical reaction or to determine whether a reaction has occurred. The key processes involve cell isolation, sample preparation, and genomic analysis, which are employed by academic institutions, biopharmaceutical companies, and clinical research organizations.

The genomics market consists of sales of genomics such as structural genomes, functional genomes, mutation genomics and comparative genomics that are used for drug discovery and development. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.